Skip to main content

Table 3 Comparison of EuroQol 5 Dimension-5 Level (EQ-5D-5 L) utility values between pre- and post-intervention

From: Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy

 

Pre-intervention

Post-intervention

P value

Utility value (IQR)

0.8197 (0.7096–0.8978)

0.8603 (0.7543–0.9384)

< 0.01

Dimension

Proportion of level ≥ 2 (%)

 

Mobility

37.1

30.5

0.014

Personal care

14.3

13.3

0.804

Usual activities

41.9

38.1

0.185

Pain/discomfort

65.2

58.6

0.071

Anxiety/depression

45.7

41.0

0.144

  1. 210 cases were analyzed. The Wilcoxon signed-rank test was used to compare the EQ-5D-5L utility value before and after pharmaceutical care. The McNemar test was used to compare percentage of level ≥ 2 in each of 5 dimensions between pre-intervention and post-intervention
Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us